Boston Scientific Corporation  

(Public, NYSE:BSX)   Watch this stock  
Find more results for MERIDIAN HEALTH SYSTEMS, INC
+0.26 (2.07%)
Real-time:   1:53PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 12.47 - 12.64
52 week 11.10 - 14.08
Open 12.47
Vol / Avg. 13.33M/12.82M
Mkt cap 16.37B
P/E 69.67
Div/yield     -
EPS 0.18
Shares 1.33B
Beta 1.11
Inst. own 91%
Oct 22, 2014
Q3 2014 Boston Scientific Corp Earnings Release
Oct 22, 2014
Q3 2014 Boston Scientific Corp Earnings Call - Webcast
Sep 17, 2014
Boston Scientific Corp at Bank of America Merrill Lynch Global Healthcare Conference
Sep 8, 2014
Boston Scientific Corporation at Morgan Stanley Healthcare Conference - Webcast
Aug 7, 2014
Boston Scientific Corp at Piper Jaffray Heartland Summit (Getting New Devices Into Hospitals)
Aug 7, 2014
Boston Scientific Corp at Piper Jaffray Heartland Summit (Heart Failure from a Device Perspective)
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 0.21% -1.69%
Operating margin -3.68% 1.68%
EBITD margin - 22.34%
Return on average assets 0.10% -0.72%
Return on average equity 0.25% -1.80%
Employees 23,000 -
CDP Score - 44


MARLBOROUGH, MA 01752-1234
United States - Map
+1-508-6834000 (Phone)
+1-508-6508923 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women�s Health, Neuromodulation, and Electrophysiology. In November 2013, the Company announced that it has acquired Bard EP, the electrophysiology (EP) business of C.R. Bard, Inc. In February 2014, Boston Scientific Corp acquired StarMedTec GmbH, a Starnberg-based manufacturer of medical laser systems. Effective May 7, 2014, the Company acquired the remaining 72% interest, which it did not already own, in IoGyn Inc.

Officers and directors

Peter M. Nicholas Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael F. Mahoney President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Joseph M. Fitzgerald Executive Vice President and President - Rhythm Management
Age: 50
Bio & Compensation  - Reuters
Daniel Brennan Chief Financial Officer, Executive Vice President
Age: 48
Bio & Compensation  - Reuters
Timothy A. Pratt Chief Administrative Officer, Executive Vice President, General Counsel, Secretary
Age: 64
Bio & Compensation  - Reuters
Supratim Bose Executive Vice President and President - Asia-Pacific, Middle East and Africa
Age: 61
Bio & Compensation  - Reuters
Keith D. Dawkins M.D. Global Chief Medical Officer, Executive Vice President
Age: 63
Bio & Compensation  - Reuters
Michael P. Phalen Executive Vice President and President - MedSurg
Age: 54
Bio & Compensation  - Reuters
Kenneth J. Pucel Executive Vice President - Global Operations, Quality and Technology
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jean Fitterer Lance Chief Compliance Officer, Senior Vice President
Age: 52
Bio & Compensation  - Reuters